Table 2.
Cytokine concentrations (pg/mL) in pregnant women from rural Bangladesh (2007–2010) at first TM, third TM, and 3 months PP by case–control status (N = 40 seroconverters and 40 controls)
Pro-inflammatory cytokines (Th1) Median (IQR) | Anti-inflammatory cytokines (Th2) Median (IQR) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
IFN-γ | IL-12 | IL-1β | IL-2 | IL-8 | TNF-α | IL-10 | IL-13 | IL-4 | IL-5 | |
First TM | ||||||||||
Controls | 1.94 (1.3, 3.4) | 2.43 (1.4, 4.2) | 0.31 (0.3, 0.5) | 1.69 (0.8, 2.6) | 6.85 (4.6, 8.3) | 9.54 (7.9, 11) | 2.04 (1.6, 3.3) | 1.96 (0.7, 3.3) | 0.39 (0.4, 0.9) | 2.14 (1.3, 2.9) |
Seroconverters | 2.58 (1.6, 3.7) | 4.57 (1.9, 8.9) | 0.31 (0.3, 0.7) | 1.75 (1.2, 2.6) | 10.0 (6.4, 34) | 10.0 (8.2, 12) | 3.11 (2.3, 5.2) | 2.35 (0.7, 3.9) | 0.79 (0.4, 1.2) | 2.18 (1.4, 3.9) |
P value* | 0.30 | 0.08 | 0.26 | 0.57 | 0.008 | 0.33 | 0.002 | 0.52 | 0.08 | 0.42 |
Third TM | ||||||||||
Controls | 1.84 (1.2, 3.6) | 2.55 (1.4, 3.5) | 0.71 (0.3, 1.0) | 1.75 (1.0, 2.6) | 9.62 (5.6, 18) | 9.05 (7.8, 11) | 2.41 (1.8, 3.6) | 2.14 (1.5, 3.6) | 0.89 (0.4, 1.3) | 1.38 (1.0, 2.5) |
Seroconverters | 1.65 (1.2, 2.3) | 4.18 (2.2, 7.1) | 0.31 (0.3, 0.8) | 1.78 (0.9, 3.3) | 11.3 (8.2, 17) | 8.62 (7.6, 11) | 3.00 (1.9, 4.4) | 2.03 (0.7, 3.9) | 0.82 (0.4, 1.4) | 1.76 (1.1, 3.1) |
P value* | 0.25 | 0.02 | 0.17 | 0.96 | 0.50 | 0.35 | 0.21 | 0.50 | 0.89 | 0.15 |
3 months PP | ||||||||||
Controls | 1.73 (1.3, 3.2) | 2.90 (2.0, 5.4) | 0.31 (0.3, 0.8) | 1.94 (1.5, 2.7) | 14.1 (8.1, 23) | 10.6 (9.0, 13) | 2.13 (1.6, 3.5) | 2.20 (0.7, 3.4) | 0.39 (0.4, 0.9) | 3.23 (2.1, 4.1) |
Seroconverters | 2.06 (1.6, 3.4) | 3.89 (2.1, 6.5) | 0.67 (0.3, 1.1) | 2.71 (1.7, 4.0) | 15.4 (8.5, 30) | 11.3 (10, 13) | 3.47 (2.2, 6.3) | 1.96 (0.7, 4.3) | 0.84 (0.4, 1.2) | 2.73 (2.0, 4.2) |
P value* | 0.13 | 0.34 | 0.18 | 0.03 | 0.52 | 0.14 | 0.005 | 0.90 | 0.13 | 0.67 |
IFN = interferon; IL = interleukin; IQR = interquartile range; PP = postpartum; Th = T-helper cell; TM = trimester; TNF-α = tumor necrosis factor alpha.
Kruskall–Wallis test comparing seroconverters to controls.